The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease
Authors:
- 29 December 2011
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 27 (7) , 2862-2865
Abstract
The epidemic of obesity and diabetes is increasing within the USA and worldwide. We have previously shown that body mass index has increased significantly in autosomal dominant polycystic kidney disease (ADPKD) subjects seen at our center in more recent years. However, the impact of Type II diabetes in ADPKD patients has not been well studied. This retrospective cohort study compared clinical characteristics in 44 pre-renal transplant patients with ADPKD and diabetes and 88 age- and sex-matched non-diabetic patients with ADPKD who were seen at the University of Colorado between 1977 and 2008. The primary outcomes in this study were renal volume determined by renal ultrasonography, renal function assessed by estimated glomerular filtration rate and time to onset of end-stage renal disease or death by Kaplan-Meier analyses. Diabetic patients had significantly larger kidney volumes than those with ADPKD alone [geometric mean (95% confidence interval (CI)]: 2456 (1510-3992) versus 1358 (1186-1556) cm3, P=0.02. Among those whose age at hypertension diagnosis was known, the diabetic ADPKD patients had earlier median (95% CI) age at onset of hypertension compared to those with ADPKD alone: 32.5 (28-40) versus 38 (35-42) years, P=0.04. Diabetic ADPKD patients tended to have an earlier median age of death than those with ADPKD alone. Patients with ADPKD and type II diabetes have larger renal volumes, earlier age at diagnosis of hypertension and may die at a younger age compared to those patients with ADPKD alone. This study emphasizes the importance of diabetes risk management in ADPKD.Keywords
This publication has 15 references indexed in Scilit:
- Use of Antihypertensive Medications and Mortality of Patients With Autosomal Dominant Polycystic Kidney Disease: A Population-Based StudyAmerican Journal of Kidney Diseases, 2011
- Metabolic Syndrome Components in Patients with Autosomal-Dominant Polycystic Kidney DiseaseKidney and Blood Pressure Research, 2009
- The ratio between kidney volume and function increases with the progression of nephropathy in Type 2 diabetesClinical Nephrology, 2009
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 DiabetesNew England Journal of Medicine, 2009
- Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney diseaseMedical Hypotheses, 2009
- Variation in Age at ESRD in Autosomal Dominant Polycystic Kidney DiseaseAmerican Journal of Kidney Diseases, 2008
- Definition of Metabolic SyndromeCirculation, 2004
- Epidemiological study of kidney survival in autosomal dominant polycystic kidney diseaseKidney International, 2003
- Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: Contribution of extrarenal complications to mortalityAmerican Journal of Kidney Diseases, 2001
- Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1The Lancet, 1994